Xtovia — Audym Lifesciences & Research Private Limited
U20236KA2025PTC196912ActivePrivateUnlisted
Last updated: 2026-06-08
75
Compliance Health · B · provisional
2 / 3 signals passed
Audym Lifesciences & Research Private Limited is a Private Indian company incorporated in 2025 and based in Karnataka, India. Audym Lifesciences & Research Private Limited operates in Wood Products (NIC 20236) with authorized capital of —. RegisterKaro's provisional Compliance Health Score for the company is 75/100 (grade B), based on 3 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7
Revenue (latest FY)
Awaiting extraction
PAT (latest FY)
Awaiting extraction
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
Filings on Record
0
All current
Incorporated
2025
1 years old
State
Karnataka
Sector
Wood Products
NIC 20236
Class
Private
Sub-category
—
Authorized Capital
—
Paid-up Capital
—
Members
—
Last AGM
—
Last Balance Sheet
—
Latest Filing
—
Registered Email
—
Registered Office
—
Xtovia
Brand Xtovia · Legal entity Audym Lifesciences & Research Private Limited
Xtovia - Manufacturer of hair care products utilizing proprietary technology to repair hair structure. Raised a total funding of $777K over 3 rounds from 13 investors.
Total Funding
Latest Round
Seed
Revenue
Valuation
Funding Rounds
—
Employees
—
Stage
Seed
HQ
Hyderabad
Founded
2024
Joined to MCA on CIN U20236KA2025PTC196912
Quick facts
Registered office
—
NIC code
20236
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
—
Section
Wood Products
ROC
—
Website
—
Class · sub-category
Private
Incorporation · Last AGM
— · —
Directors
LockedSI
Suresh Iyer
Director6.5y · Gurugram · DIN 2343274
SG
Sneha Gupta
Whole-time Director6.1y · Ahmedabad · DIN 4661050
PN
Priya Nair
Managing Director8.9y · Bengaluru · DIN 5217993
Get the full board of directors
Directors, DINs & appointment history for Audym Lifesciences & Research Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +16d | filed |
| MGT-7 | FY2022-23 | 22 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Audym Lifesciences & Research Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 878136102 | ICICI Bank Ltd(Bank) | ₹2.67 Cr | 27 Jan 2020 | Satisfied |
| 774256388 | HDFC Bank Ltd(Bank) | ₹19.04 Cr | 19 Sep 2021 | Open |
| 654059109 | State Bank of India(Bank) | ₹4.52 Cr | 19 Sep 2020 | Open |
| 165374816 | ICICI Bank Ltd(Bank) | ₹11.54 Cr | 04 Jul 2023 | Open |
| 193682094 | Axis Bank Ltd(Bank) | ₹4.26 Cr | 19 Sep 2021 | Open |
| 136385979 | ICICI Bank Ltd(Bank) | ₹1.50 Cr | 12 Mar 2020 | Open |
See registered charges & lenders
Charge IDs, lenders & amounts for Audym Lifesciences & Research Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹46.71 Cr | ₹1.16 Cr | ₹24.00 Cr | ₹69.80 Cr | 52 |
| FY2023-24 | ₹41.55 Cr | ₹1.81 Cr | ₹37.56 Cr | ₹61.91 Cr | 327 |
| FY2022-23 | ₹39.81 Cr | ₹95.56 L | ₹25.32 Cr | ₹56.18 Cr | 203 |
| FY2021-22 | ₹24.42 Cr | ₹1.09 Cr | ₹12.01 Cr | ₹35.55 Cr | 99 |
Gain deeper financial insights of this entity
Audited financials & ratios for Audym Lifesciences & Research Private Limited.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹46.71 Cr | ₹41.55 Cr | ₹39.81 Cr | ₹24.42 Cr |
| Other income | ₹38.75 L | ₹56.94 L | ₹1.40 Cr | ₹72.44 L |
| Total income | ₹47.10 Cr | ₹42.12 Cr | ₹41.21 Cr | ₹25.14 Cr |
| Total expenses | ₹45.61 Cr | ₹39.80 Cr | ₹39.99 Cr | ₹23.74 Cr |
| Profit before tax | ₹1.51 Cr | ₹2.35 Cr | ₹1.24 Cr | ₹1.42 Cr |
| Profit / (Loss) after tax | ₹1.16 Cr | ₹1.81 Cr | ₹95.56 L | ₹1.09 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹24.00 Cr | ₹37.56 Cr | ₹25.32 Cr | ₹12.01 Cr |
| Borrowings | ₹14.93 Cr | ₹6.92 Cr | ₹12.49 Cr | ₹6.15 Cr |
| Current liabilities | ₹19.44 Cr | ₹8.52 Cr | ₹9.85 Cr | ₹14.07 Cr |
| Total liabilities | ₹45.80 Cr | ₹24.35 Cr | ₹30.86 Cr | ₹23.54 Cr |
| Current assets | ₹28.96 Cr | ₹35.76 Cr | ₹22.86 Cr | ₹17.44 Cr |
| Cash & equivalents | ₹9.06 Cr | ₹8.45 Cr | ₹6.82 Cr | ₹3.38 Cr |
| Total assets | ₹69.80 Cr | ₹61.91 Cr | ₹56.18 Cr | ₹35.55 Cr |
| Employees | 52 | 327 | 203 | 99 |
Gain deeper financial insights of this entity
Audited financials & ratios for Audym Lifesciences & Research Private Limited.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹46.71 Cr | +9.8% | +28.0% | -1.1% |
| Profit after Tax | ₹1.16 Cr | +24.8% | +13.4% | +13.8% |
| Net Worth | ₹24.00 Cr | -10.6% | +26.8% | +3.2% |
| Employees | 52 | +10.5% | +18.9% | +11.3% |
Gain deeper financial insights of this entity
Audited financials & ratios for Audym Lifesciences & Research Private Limited.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹46.71 Cr | ₹1.16 Cr | +2.49% | -9.60% | +4.85% | +1.67% | 0.62 | ₹89.83 L |
| FY2023-24 | ₹41.55 Cr | ₹1.81 Cr | +4.36% | -3.90% | +4.82% | +2.93% | 0.18 | ₹12.71 L |
| FY2022-23 | ₹39.81 Cr | ₹95.56 L | +2.40% | +17.19% | +3.77% | +1.70% | 0.49 | ₹19.61 L |
| FY2021-22 | ₹24.42 Cr | ₹1.09 Cr | +4.48% | +9.85% | +9.12% | +3.08% | 0.51 | ₹24.66 L |
Gain deeper financial insights of this entity
Audited financials & ratios for Audym Lifesciences & Research Private Limited.
What you'll get
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 2,08,04,651 | 77.94% |
| Institutional Investors | 1 | 29,04,954 | 10.88% |
| Public & Others | 8 | 29,82,875 | 11.17% |
See the full shareholding pattern
Promoter, institutional & public holding for Audym Lifesciences & Research Private Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
3 peersMetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
—
PAT (latest FY)
—
Employees
—
—
—
—
Paid-up capital
—
Compliance Health
58
63
96
Bottom quartile · P0
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Audym Lifesciences & Research Private Limited
When was Audym Lifesciences & Research Private Limited incorporated?
Audym Lifesciences & Research Private Limited was incorporated in 2025. Its CIN is U20236KA2025PTC196912 and it is registered with the relevant Registrar of Companies.
Where is Audym Lifesciences & Research Private Limited located?
Audym Lifesciences & Research Private Limited is headquartered in Karnataka.
What sector does Audym Lifesciences & Research Private Limited operate in?
Audym Lifesciences & Research Private Limited operates in the Wood Products sector (NIC code 20236), classified as Indian Non-Govt Company.
Who are the directors of Audym Lifesciences & Research Private Limited?
Director details for Audym Lifesciences & Research Private Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Audym Lifesciences & Research Private Limited?
Audym Lifesciences & Research Private Limited has authorized capital of — and paid-up capital of —.
Does Audym Lifesciences & Research Private Limited have any open charges?
Audym Lifesciences & Research Private Limited has no open MCA-registered charges on record.
What is Audym Lifesciences & Research Private Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Audym Lifesciences & Research Private Limited is 75/100 (grade B), based on 3 assessable weighted signals across charges, directors, capital, and overall status. 2 of 3 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.